APA (7th ed.) Citation

I, G., D, K., G, E., GI, R., DS, S., R, O., . . . SB, K. (2000). A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(3), 798.

Chicago Style (17th ed.) Citation

I, Ganly, et al. "A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 6, no. 3 (2000): 798.

MLA (9th ed.) Citation

I, Ganly, et al. "A Phase I Study of Onyx-015, an E1B Attenuated Adenovirus, Administered Intratumorally to Patients with Recurrent Head and Neck Cancer." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 6, no. 3, 2000, p. 798.